Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
出版年份 2021 全文链接
标题
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
作者
关键词
-
出版物
LANCET ONCOLOGY
Volume 22, Issue 8, Pages 1081-1092
出版商
Elsevier BV
发表日期
2021-07-10
DOI
10.1016/s1470-2045(21)00297-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
- (2021) Feng‐Hua Wang et al. Cancer Communications
- Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial
- (2020) Woo Jin Hyung et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501)
- (2019) Masanori Terashima et al. Gastric Cancer
- Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer
- (2019) Jiang Yu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- Perioperative FLOT: new standard for gastric cancer?
- (2019) Yoon-Koo Kang et al. LANCET
- Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?
- (2018) Pamela Minicozzi et al. EUROPEAN JOURNAL OF CANCER
- Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
- (2018) Annemieke Cats et al. LANCET ONCOLOGY
- Comparative effectiveness of preoperative, postoperative and perioperative treatments for resectable gastric cancer: A network meta-analysis of the literature from the past 20 years
- (2018) Zhaolun Cai et al. SURGICAL ONCOLOGY-OXFORD
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality
- (2017) Jae Kwan Jun et al. GASTROENTEROLOGY
- Neoadjuvant chemotherapy for gastric adenocarcinoma in Japan
- (2017) Yasuhiro Kodera SURGERY TODAY
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) E. C. Smyth et al. ANNALS OF ONCOLOGY
- Stomach cancer burden in Central and South America
- (2016) Monica S. Sierra et al. Cancer Epidemiology
- The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis
- (2016) Emil ter Veer et al. Gastric Cancer
- Gastric cancer
- (2016) Eric Van Cutsem et al. LANCET
- Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy
- (2015) Kohei Shitara et al. Gastric Cancer
- Differences in gastric cancer survival between the U.S. and China
- (2015) Vivian E. Strong et al. JOURNAL OF SURGICAL ONCOLOGY
- Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis
- (2014) A. Tsuburaya et al. BRITISH JOURNAL OF SURGERY
- Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial
- (2014) Akira Tsuburaya et al. LANCET ONCOLOGY
- Management of gastric cancer in Asia: resource-stratified guidelines
- (2013) Lin Shen et al. LANCET ONCOLOGY
- Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
- (2012) Yung-Jue Bang et al. LANCET
- Capecitabine in gastric cancer
- (2011) Yung-Jue Bang Expert Review of Anticancer Therapy
- A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer
- (2010) Sung Yong Oh et al. INVESTIGATIONAL NEW DRUGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More